Recombinant Human Antithrombin (ATryn®) in the Treatment of Patients With DIC Associated With Severe Sepsis

NCT00506519 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Disseminated Intravascular Coagulation

Interventions

DRUG: Antithrombin alfa (INN name)
DRUG: Control (Standard treatment)

Sponsor

LEO Pharma